ID22957A - Senyawa dan penggunaannya - Google Patents

Senyawa dan penggunaannya

Info

Publication number
ID22957A
ID22957A IDP990201D ID990201D ID22957A ID 22957 A ID22957 A ID 22957A ID P990201 D IDP990201 D ID P990201D ID 990201 D ID990201 D ID 990201D ID 22957 A ID22957 A ID 22957A
Authority
ID
Indonesia
Prior art keywords
compound
Prior art date
Application number
IDP990201D
Other languages
English (en)
Indonesian (id)
Inventor
Lorraine Mary Edmeades
Nigel Arthur Griffith-Skinner
Derek Anthony Hill
Graham Thronton Hill
Terence Williampackham
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10833464&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22957(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ID22957A publication Critical patent/ID22957A/id

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IDP990201D 1998-06-10 1999-03-10 Senyawa dan penggunaannya ID22957A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9812413.4A GB9812413D0 (en) 1998-06-10 1998-06-10 Compound and its use

Publications (1)

Publication Number Publication Date
ID22957A true ID22957A (id) 1999-12-23

Family

ID=10833464

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990201D ID22957A (id) 1998-06-10 1999-03-10 Senyawa dan penggunaannya

Country Status (31)

Country Link
US (1) US6333198B1 (fr)
EP (2) EP0963980B1 (fr)
JP (1) JP2989189B1 (fr)
KR (1) KR100322354B1 (fr)
CN (2) CN1238454A (fr)
AP (3) AP0102286A0 (fr)
AR (1) AR014074A1 (fr)
AT (1) ATE218552T1 (fr)
AU (1) AU2031999A (fr)
BR (1) BR9900984A (fr)
CA (1) CA2265194C (fr)
DE (1) DE69901656T2 (fr)
DK (1) DK0963980T3 (fr)
EA (1) EA000666B1 (fr)
ES (1) ES2178342T3 (fr)
GB (1) GB9812413D0 (fr)
HR (1) HRP990074A2 (fr)
HU (1) HUP9900592A3 (fr)
ID (1) ID22957A (fr)
MA (1) MA24777A1 (fr)
NO (2) NO991151L (fr)
NZ (1) NZ334590A (fr)
PE (1) PE20000332A1 (fr)
PL (1) PL331870A1 (fr)
PT (1) PT963980E (fr)
SG (1) SG85628A1 (fr)
SI (1) SI0963980T1 (fr)
TR (1) TR199900520A2 (fr)
UY (1) UY25946A1 (fr)
YU (1) YU12399A (fr)
ZA (1) ZA991951B (fr)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055177A1 (en) * 1999-03-10 2002-05-09 Glaxo Wellcome Inc. Compound and its use
AU763244B2 (en) * 2000-01-03 2003-07-17 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
US6653481B2 (en) 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
MXPA03005885A (es) 2000-12-29 2005-04-19 Pfizer Ltd Procedimiento para fabricar maleato de amlodipina.
ATE315026T1 (de) 2000-12-29 2006-02-15 Pfizer Ltd Amlodipin-hemimaleat
CA2433284A1 (fr) * 2000-12-29 2002-07-11 Pfizer Limited Standards de reference destines a la determination de la purete ou de la stabilite de maleate d'amlodipine et procedes correspondants
CA2433191A1 (fr) 2000-12-29 2002-07-11 Pfizer Limited Derive aspartate de l'amlodipine utilise comme antagoniste des canaux calciques
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
EP1309556B1 (fr) 2000-12-29 2004-11-24 Pfizer Limited Fumarate d'amlodipine
BR0116554A (pt) 2000-12-29 2004-02-03 Pfizer Ltd Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão
MXPA03005882A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
DE10134980C2 (de) * 2001-07-17 2003-05-28 Helm Ag Verfahren zur Herstellung von Lamotrigin
CA2366521C (fr) 2001-12-24 2007-03-06 Brantford Chemicals Inc. Un procede nouveau et efficace de preparation de lamotrigine et d'autres 3,5-diamino-1,2,4-triazines substituees en position 6
IL164155A0 (en) * 2002-03-20 2005-12-18 Teva Pharma Crystalline forms of quetiapine hemifumarate
HU225667B1 (en) 2002-09-20 2007-05-29 Richter Gedeon Nyrt Method for producing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
ES2209639B1 (es) 2002-10-31 2005-08-01 Vita Cientifica, S.L. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y obtencion de su intermedio.
GB2395483A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Crystalline lamotrigine and its monohydrate
CA2657076A1 (fr) 2003-08-28 2005-03-17 Teva Pharmaceutical Industries Ltd. Procede de preparation de sels calciques de rosuvastatine
CA2546701C (fr) * 2003-11-24 2010-07-27 Teva Pharmaceutical Industries Ltd. Sels d'ammonium cristallins de la rosuvastatine
WO2005056534A1 (fr) * 2003-12-02 2005-06-23 Teva Pharmaceutical Industries Ltd. Norme de reference pour la caracterisation de la rosuvastatine
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
WO2005075427A2 (fr) * 2004-01-30 2005-08-18 Teva Pharmaceutical Industries Ltd. Montelukast de sodium polymorphe
KR20060117356A (ko) * 2004-01-30 2006-11-16 테바 파마슈티컬 인더스트리즈 리미티드 몬테루카스트 유리산 다형체
MD2823G2 (ro) * 2004-02-12 2006-05-31 Институт Химии Академии Наук Молдовы Procedeu de determinare cantitativă a sclareolului în extractele, obţinute din salvia de muscat
WO2005105751A1 (fr) * 2004-04-21 2005-11-10 Teva Pharmaceutical Industries Ltd. Procedes de preparation de sodium montelukast
US7683188B2 (en) 2004-04-26 2010-03-23 TEVA Gyógyszergyár Zártkōrūen Mūkōdō Részvénytársaság Process for preparation of mycophenolic acid and ester derivatives thereof
US20050250773A1 (en) * 2004-04-27 2005-11-10 Sandor Molnar Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
EP1687254A2 (fr) * 2004-06-28 2006-08-09 Teva Pharmaceutical Fine Chemicals S.R.L. Procede pour la resolution optique et le recyclage de tamoxetine
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
WO2006017357A1 (fr) * 2004-07-13 2006-02-16 Teva Pharmaceutical Industries Ltd. Procede pour la preparation de rosuvastatine mettant en oeuvre une etape d'oxydation par tempo
US7439373B2 (en) * 2004-07-20 2008-10-21 TEVA Gyógyszergyár Zártkörúen Múködö Részvénytársaság Crystalline mycophenolate sodium
CA2568629A1 (fr) * 2004-07-22 2006-02-23 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphes du chlorhydrate d'atomoxetine
US7629461B2 (en) * 2004-09-04 2009-12-08 Teva Pharmaceutical Industries Ltd Isolated valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
CA2579997A1 (fr) * 2004-09-28 2006-04-06 Teva Pharmaceutical Industries Ltd. Procede de preparation de formes d'atorvastatine calcique sensiblement exemptes d'impuretes
WO2006045120A2 (fr) * 2004-10-19 2006-04-27 Teva Pharmaceutical Industries Ltd. Purification du maleate de tegaserod
US7678551B2 (en) * 2004-10-25 2010-03-16 Seradyn, Inc. Immunoassays for lamotrigine
JP2007523213A (ja) * 2004-12-23 2007-08-16 テバ ファーマシューティカル インダストリーズ リミティド 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
PT1836157E (pt) * 2005-01-11 2009-11-24 Teva Pharm Fine Chemicals Srl Polimorfos de cloridrato de memantina
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
JP4713574B2 (ja) 2005-02-22 2011-06-29 テバ ファーマシューティカル インダストリーズ リミティド ロスバスタチンアルキルエーテルを含まないロスバスタチンおよびその塩およびそれらを製造する方法
US7291614B2 (en) * 2005-02-24 2007-11-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
EP1858859A1 (fr) * 2005-03-14 2007-11-28 Teva Pharmaceutical Industries Ltd. Procede de preparation du compose optiquement actif (s)-(+)-n,n-dimethyl-3-(1-naphtalenyloxy)-3-(2-thienyl)propanamine
WO2006108120A1 (fr) * 2005-04-05 2006-10-12 Teva Pharmaceutical Fine Chemicals S.R.L. Chlorhydrate d’atomoxetine stable, procede de preparation dudit chlorhydrate d’atomoxetine et controle analytique de sa stabilite
CN101160281A (zh) * 2005-04-06 2008-04-09 特瓦制药工业有限公司 结晶形态的普瑞巴林
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
MX2007012606A (es) * 2005-04-11 2008-01-11 Teva Pharma Proceso para elaborar (s)-pregabalina.
CA2603795A1 (fr) * 2005-04-14 2006-10-26 Teva Pharmaceutical Industries Ltd. Processus de preparation de fumarate de quetiapine
US20080281111A1 (en) * 2005-04-26 2008-11-13 Sandor Molnar Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
WO2006121557A1 (fr) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Pregabaline exempte de lactame et son procede de preparation
JP2008505980A (ja) * 2005-05-10 2008-02-28 テバ ファーマシューティカル インダストリーズ リミティド イソブチルグルタル酸を有さないプレガバリン及びその調製方法
CA2604624A1 (fr) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Resolution optique de l'acide 3-carbamoylmethyl-5-methyl hexanoique
EP1879851B1 (fr) * 2005-05-10 2010-11-03 Teva Pharmaceutical Industries Ltd Procede pour preparer de la pregabaline et des sels de celle-ci
ATE445587T1 (de) 2005-05-23 2009-10-15 Teva Pharma Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i
CA2606945A1 (fr) * 2005-06-27 2007-01-04 Sicor, Inc. Impurete d'un intermediaire de l'anastrozole, et ses applications
BRPI0605902A (pt) * 2005-06-27 2007-12-18 Sicor Inc processo de purificação para intermediário de anastrozol
EP1904448B1 (fr) * 2005-07-05 2011-02-02 Teva Pharmaceutical Industries, Ltd. Purification du montélukast
EP1805148A2 (fr) * 2005-08-16 2007-07-11 Teva Pharmaceutical Industries Ltd. Intermediaire de rosuvastatine sous forme cristalline
CA2619472A1 (fr) * 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. Acides 3-carbamoylmethyl-5-methylhexanoiques chiraux, intermediaires cles pour la nouvelle synthese de la (s)-pregabaline
US20070197529A1 (en) * 2005-12-01 2007-08-23 Viviana Braude Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard
WO2007067581A1 (fr) 2005-12-05 2007-06-14 Teva Pharmaceutical Industries Ltd. 2-(n-methyl-propanamine)-3-(2-naphtol)thiophene, une impurete du duloxetine chlorhydrate
WO2007069264A2 (fr) * 2005-12-15 2007-06-21 Alembic Limited Nouveaux composes
EP1966179A2 (fr) * 2005-12-27 2008-09-10 Teva Pharmaceutical Industries Ltd Bromhydrate de darifenacine pur sensiblement exempt de darifenacine oxydee, sels de celui-ci, et procedes de preparation de ceux-ci
EP1999100A1 (fr) * 2006-03-27 2008-12-10 Teva Pharmaceutical Fine Chemicals S.R.L. Procédé de synthèse de chlorhydrate de mémantine ne contenant essentiellement aucune impureté
US20080146675A1 (en) * 2006-04-05 2008-06-19 Eugenio Castelli Stable Atomoxetine Hydrochloride, a process for the preparation thereof, and an analytical control of its stability
GB0609835D0 (en) * 2006-05-18 2006-06-28 Pliva Istrazivanje I Razvoj D Impurities of a pharmaceutical product
TW200815323A (en) * 2006-05-24 2008-04-01 Teva Pharma Processes for the preparation of R-(+)-3-(carbamoylmethyl)-5-methylhexanoic acid and salts thereof
EP2071032A3 (fr) * 2006-05-31 2009-07-08 Teva Pharmaceutical Industries Ltd Utilisation d'une résolution enzymatique pour la préparation d'intermédiaires de la prégabaline
US20080015385A1 (en) * 2006-05-31 2008-01-17 Lilach Hedvati Preparation of (S)-pregabalin-nitrile
DE602007004728D1 (de) * 2006-06-29 2010-03-25 Ivax Pharmaceuticals Sro Regulation der säuremetabolitproduktion
US20120142919A1 (en) * 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
EP2054396A1 (fr) * 2006-08-14 2009-05-06 Lonza Ag Procédé de préparation de lamotrigine
US20080242877A1 (en) * 2007-02-26 2008-10-02 Vinod Kumar Kansal Intermediates and processes for the synthesis of Ramelteon
BRPI0803092A2 (pt) * 2007-03-22 2011-08-30 Teva Pharma sìntese de (s)-(+)-3-(aminometil)-5-metil ácido hexanóico, (s)-pregabalina
TW200904982A (en) * 2007-04-11 2009-02-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Method for reducing impurity level in mycophenolic acid fermentation
EP2098519A1 (fr) * 2007-05-31 2009-09-09 Teva Pharmaceutical Industries Ltd. Procédé de synthèse du rameltéon et ses intermédiaires
US20090137842A1 (en) * 2007-10-03 2009-05-28 Vollerner Yuri Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof
EP2508523B2 (fr) * 2007-10-23 2019-04-17 Teva Pharmaceutical Industries Ltd. Polymorphes de dasatinib et leur procédé de préparation
WO2009056993A2 (fr) * 2007-11-01 2009-05-07 Teva Pharmaceutical Industries Ltd. Procédé de synthèse de rameltéon et intermédiaires de ce dernier
WO2009061513A1 (fr) * 2007-11-09 2009-05-14 Thar Pharmaceuticals Formes cristallines de lamotrigine
WO2009151494A1 (fr) * 2008-03-06 2009-12-17 Teva Pharmaceutical Industries Ltd. Procédés de préparation de la o-desméthylvenlafaxine, exempte de ses impuretés dimères
KR20100107500A (ko) * 2008-06-23 2010-10-05 테바 파마슈티컬 인더스트리즈 리미티드 (ｓ) 또는 (ｒ)-이소-부틸-글루타릭 에스테르의 입체선택적 효소 합성방법
US20100152468A1 (en) * 2008-10-16 2010-06-17 Teva Pharmaceutical Industries Ltd. Process for the synthesis of ramelteon and its intermediates
CA2795023A1 (fr) * 2010-03-29 2011-10-06 Pliva Hrvatska D.O.O. Formes cristallines du fumarate de o-desmethylvenlafaxine
WO2012034065A1 (fr) 2010-09-09 2012-03-15 Teva Pharmaceutical Industries Ltd. Intermédiaires d'aliskirène et procédé destiné à analyser la pureté de l'aliskirène
CN102766104A (zh) * 2012-08-20 2012-11-07 三金集团湖南三金制药有限责任公司 一种治疗双向情感障碍及癫痫病药物拉莫三嗪的合成方法
WO2015092819A2 (fr) * 2013-12-21 2015-06-25 Nektar Therapeutics (India) Pvt. Ltd. Dérivés de 6- (2,3-dichlorophényl) -1,2,4-triazin -5-amine
CN110467560A (zh) 2018-05-09 2019-11-19 深圳微芯生物科技股份有限公司 一种苯基氨基丙酸钠衍生物、其制备方法和应用
KR102270026B1 (ko) * 2020-01-31 2021-06-28 현대약품 주식회사 (3s)-3-(4-(3-(1,4-다이옥사스파이로[4,5]데스-7-엔-8-일)벤질옥시)페닐)헥스-4-이노익산의 품질 평가 방법
CN113156009B (zh) * 2021-04-20 2023-12-22 三金集团湖南三金制药有限责任公司 高效液相色谱分析拉莫三嗪的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530999B2 (en) 1979-06-01 1983-08-04 Wellcome Foundation Limited, The Substituted amino triazines and their use in treatment of cns disorders
EP0021120B1 (fr) 1979-06-01 1983-04-06 The Wellcome Foundation Limited Dérivés de la diamino-3,5 triazine-1,2,4, procédé pour la préparation de tels composés et compositions pharmaceutiques les contenant
GB8613183D0 (en) 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9426448D0 (en) * 1994-12-30 1995-03-01 Wellcome Found Process
PT800520E (pt) * 1994-12-30 2002-11-29 Wellcome Found Processo para a preparacao de lamotrigina
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation

Also Published As

Publication number Publication date
EP0963980A2 (fr) 1999-12-15
EP1170588A1 (fr) 2002-01-09
CN1238454A (zh) 1999-12-15
CA2265194C (fr) 2000-10-10
NO991151L (no) 1999-12-13
ATE218552T1 (de) 2002-06-15
HUP9900592A3 (en) 2002-04-29
JP2000009714A (ja) 2000-01-14
MA24777A1 (fr) 1999-10-01
AP2001002286A0 (en) 2001-12-31
NO20032753L (no) 1999-12-13
PT963980E (pt) 2002-10-31
AP0102286A0 (en) 2000-09-10
PE20000332A1 (es) 2000-04-10
KR20000005611A (ko) 2000-01-25
ZA991951B (en) 1999-08-16
SG85628A1 (en) 2002-01-15
CN1306210A (zh) 2001-08-01
TR199900520A3 (tr) 2000-01-21
EP0963980B1 (fr) 2002-06-05
HRP990074A2 (en) 2000-10-31
HUP9900592A2 (hu) 2000-04-28
DK0963980T3 (da) 2002-09-16
GB9812413D0 (en) 1998-08-05
AP9901481A0 (en) 1999-03-31
EA000666B1 (ru) 2000-02-28
TR199900520A2 (en) 2000-01-21
PL331870A1 (en) 1999-12-20
EA199900159A1 (ru) 1999-12-29
JP2989189B1 (ja) 1999-12-13
NO20032753D0 (no) 2003-06-17
DE69901656D1 (de) 2002-07-11
NZ334590A (en) 2000-07-28
UY25946A1 (es) 2000-12-29
YU12399A (sh) 2002-08-12
AU2031999A (en) 2000-01-06
AR014074A1 (es) 2001-01-31
BR9900984A (pt) 2000-05-02
US6333198B1 (en) 2001-12-25
ES2178342T3 (es) 2002-12-16
DE69901656T2 (de) 2003-01-30
EP0963980A3 (fr) 2000-05-31
HU9900592D0 (en) 1999-04-28
NO991151D0 (no) 1999-03-10
KR100322354B1 (ko) 2002-02-07
SI0963980T1 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
ID22957A (id) Senyawa dan penggunaannya
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
ID24196A (id) Komposisi dan penggunaan
ID28990A (id) Herbisida-herbisida dengan urea aminofenilsulfonil asilasi
ID19422A (id) Piridina dan bifenil tersubstitusi
ID24148A (id) Turunan-turunan fitostfrol dan/atau fitostanol
ID25977A (id) Popok sekali pakai
ID24555A (id) Popok sekali pakai
ID26848A (id) Koupling untuk gigi-gigi eksapator dan sejenisnya
ID23076A (id) Popok sekali pakai
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
NO20005503D0 (no) Ny anvendelse
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ID29943A (id) Senyawa dds dan metode pengukurannya
ID26599A (id) Turunan triazola dan imidazola
ID22956A (id) Sintesa disulfida dan polisulfida organik
ID27480A (id) Pembungkusan berstruktur dan elemennya
ID28852A (id) Bahan-bahan elektroluminesensi
ID23083A (id) Popok sekali pakai
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID26156A (id) Benzotiadiazol dan turunan-turunan